Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma

Gynecologic Oncology

Volumn 129, Issue 1, 2013, Pages 120-123

  Lengyel, Ernst ^a   Fleming, Saroj ^b   McEwen, Kelsey A ^a   Montag, Anthony ^a   Temkin, Sarah M ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Fallopian tube carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPARATIVE STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PERITONEUM CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; UTERINE TUBE; UTERINE TUBE CARCINOMA;

AGED; FALLOPIAN TUBE NEOPLASMS; FALLOPIAN TUBES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84884213524     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.12.006     Document Type: Article

References (22)

1. R.E. Scully Early de novo ovarian cancer and cancer developing in benign ovarian lesions Int J Gynecol Obstet 49 1995 S9 S15 [Supplement]
2. D.A. Bell, and R.E. Scully Early de novo ovarian carcinoma. A study of fourteen cases Cancer 73 1994 1859 1864
3. E. Lengyel Ovarian cancer development and metastasis Am J Pathol 177 2010 1053 1064
4. N. Auersperg, T. Ota, and W. Mitchell Early events in ovarian carcinogenesis: progress and problems in experimental approaches Int J Gynecol Cancer 12 2002 691 703
5. D.A. Bell Origins and molecular pathology of ovarian cancer Mod Pathol 18 2005 S19 S32
6. C.G. Przybycin, R.J. Kurman, B.M. Ronnett, I.-M. Shih, and R. Vang Are all pelvic (Nonuterine) serous carcinomas of tubal origin? Am J Surg Pathol 34 2010 1407 1416
7. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
8. S.L. Stewart, J.M. Wike, S.L. Foster, and F. Michaud The incidence of primary fallopian tube cancer in the United States Gynecol Oncol 107 2007 392 397
9. K.A. Rosenblatt, N.S. Weiss, and S.M. Schwartz Incidence of malignant fallopian tube tumors Gynecol Oncol 35 1989 236 239
10. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2009 80 87
11. N.D. Kauff, J.M. Satagopan, M.E. Robson, L. Scheuer, M. Hensley, and C.A. Hudis Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 Mutation N Engl J Med 346 2002 1609 1615
12. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. van't Veer, and J.E. Garber Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622
13. J.M.J. Piek, P.J. van Diest, R.P. Zweemer, J.W. Jansen, R.J.J. Poort-Keesom, and F.H. Menko Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer J Pathol 195 2001 451 456
14. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 2006 58 64
15. C.B. Powell, E. Kenley, L. Chen, B. Crawford, J. McLennan, and C. Zaloudek Risk reducing salpingo-oophorectomy in BRCA mutation carriers:role of serial sectioning in the detection of occult malignancy J Clin Oncol 23 2005 127 132
16. M.J. Callahan, C.P. Crum, F. Medeiros, D.W. Kindelberger, J.A. Elvin, and J.E. Garber Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction J Clin Oncol 25 2007 3985 3990
17. K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley Pathologic findings in prophylactic oophorectomy specimens in high-risk women Gynecol Oncol 87 2002 52 56
18. J.W. Carlson, A. Miron, E.A. Jarboe, M.M. Parast, M.S. Hirsch, and Y. Lee Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J Clin Oncol 26 2008 4160 4165
19. J.D. Seidman, P. Zhao, and A. Yemelyanova Primary peritoneal high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer Gynecol Oncol 120 2011 470 473
20. D. Kindelberger, Y. Lee, A. Miron, M.S. Hirsch, C.M. Feltmate, and F. Medeiros Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship Am J Surg Pathol 31 2007 161 169
21. M.H. Roh, D. Kindelberger, and C.P. Crum Serous tubal intraepithelial carcinoma and the dominant ovarian mass Am J Surg Pathol 33 2009 376 383
22. K.N. Moore, K.M. Moxley, A.N. Fader, A.E. Axtell, R.P. Rocconi, and L.N. Abaid Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary Gynecol Oncol 107 2007 398 403